K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Paul G. Richardson
also known as Albert Oriol, Anderson, Kenneth C., P G Richardson
Harvard University · Dana-Farber Cancer Institute · Broad Institute · Dartmouth College
About this author
Works
2,061
Cited by
131,948
h-index
170
i10
883
ORCID ↗
Top papers
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo, et al.
·
2014
·
The Lancet Oncology
↗ 4,809
OA
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C. Anderson, et al.
·
2016
·
The Lancet Oncology
↗ 2,939
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake Delmore, Ghayas C. Issa, Madeleine E. Lemieux, et al.
·
2011
·
Cell
↗ 2,828
OA
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Paul G. Richardson, Bart Barlogie, James R. Berenson, et al.
·
2003
·
New England Journal of Medicine
↗ 2,635
OA
International uniform response criteria for multiple myeloma
Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel, et al.
·
2006
·
Leukemia
↗ 2,632
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, et al.
·
2005
·
New England Journal of Medicine
↗ 2,492
OA
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
Jesús F. San Miguel, Rudolf Schlag, Nuriet K. Khuageva, et al.
·
2008
·
New England Journal of Medicine
↗ 1,904
OA
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.
Teru Hideshima, Paul G. Richardson, D Chauhan, et al.
·
2001
·
PubMed
↗ 1,530
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Meletios Α. Dimopoulos, Albert Oriol, Hareth Nahi, et al.
·
2016
·
New England Journal of Medicine
↗ 1,428
OA
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo, et al.
·
2015
·
New England Journal of Medicine
↗ 1,314
OA
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
Michel Attal, Valérie Lauwers‐Cancès, Cyrille Hulin, et al.
·
2017
·
New England Journal of Medicine
↗ 1,223
OA
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister, et al.
·
2012
·
New England Journal of Medicine
↗ 1,140
OA
Books
Multiple Myeloma (State of the Art)
2004
·
Remedica Publishing
Bortezomib in the Treatment of Multiple Myeloma
2010
·
Springer